Edward T. Mathers - Mar 2, 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Stock symbol
RYTM
Transactions as of
Mar 2, 2023
Transactions value $
$0
Form type
4
Date filed
3/6/2023, 12:47 PM
Previous filing
Jan 3, 2023
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Other $0 +5.77K $0.00 5.77K Mar 2, 2023 See Note 2 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 5,771 shares of Common Stock of the Issuer in the distribution by NEA Partners 13, L.P. on March 2, 2023.
F2 The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.